Literature DB >> 2053222

Clinical manifestation of human T-cell lymphotropic virus type-I-associated myelopathy and vesicopathy.

A Imamura1, T Kitagawa, Y Ohi, M Osame.   

Abstract

Patients with human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy (HAM) sometimes have accompanying voiding disturbances. We performed clinical surveys and urodynamic examinations on 25 untreated patients with HAM. Although 4 cases (16%) were entirely aware of urinary symptoms, the onset of urinary symptoms preceded other pyramidal symptoms in 6 cases (24%). All cases suffered from dysuria. The cause of dysuria was thought mainly to be detrusor external sphincter dyssynergia, but in some cases an underactive detrusor and poor opening of the bladder neck at voiding were also the causes of dysuria. There was a tendency for urinary dysfunction to become worse as the primary disease progresses. Patients with HAM must be carefully followed up by urologists in order to prevent deterioration of the urinary tract.

Entities:  

Mesh:

Year:  1991        PMID: 2053222     DOI: 10.1159/000282121

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.

Authors:  Davi Tanajura; Néviton Castro; Paulo Oliveira; Abraão Neto; André Muniz; Natália B Carvalho; Glória Orge; Silvane Santos; Marshall J Glesby; Edgar M Carvalho
Journal:  Clin Infect Dis       Date:  2015-03-27       Impact factor: 9.079

2.  Concomitant presence of bladder cancer and neurogenic bladder in a patient with HTLV-1 carrier: a case report.

Authors:  H Yagi; M Igawa; H Shiina; K Shigeno
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.266

3.  Detrusor Arreflexia as an End Stage of Neurogenic Bladder in HAM/TSP?

Authors:  Matheus Tannus; Davi Tanajura; Michael A Sundberg; Paulo Oliveira; Neviton Castro; André Muniz Santos
Journal:  Case Rep Med       Date:  2011-04-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.